Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Jones

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
The Journal of Urology|June 1, 1980
Giant abdominal mass in a patient with an 18-year surgical cure of liposarcoma of the lower extremityR F Jones, T G Rudd, H J Ricketts, et al.
Urologic Oncology|January 14, 2011
Immunotherapy and gene therapy for renal cell carcinomaN Nishisaka, R F Jones, A Maini, et al.
Series Haematologica (1968)|January 1, 1971
Biologically active messenger-RNA for hemoglobinJ B Lingrel, R E Lockard, R F Jones, et al.
Virology|April 15, 1982
Mouse mammary tumor virus DNA sequences in tumorigenic and nontumorigenic cells from a mammary adenocarcinomaV L Morris, D A Gray, R F Jones, et al.
Anticancer Research|March 4, 2000
Expression of p53 and pRb in bladder and prostate cancers of patients having both cancersA Singh, R F Jones, H Friedman, et al.
Cancer Letters|May 18, 2000
Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the ratC L Archer, P Morse, R F Jones, et al.
Anticancer Research|September 1, 1995
Maintenance of human hyperplastic prostate implants at different sites in athymic miceG Soós, M Debiec-Rychter, R F Jones, et al.
Cytokines, Cellular & Molecular Therapy|September 22, 2001
Inhibition of lung metastases of murine renal cell carcinoma by the combination of radiation and interferon-alpha-producing tumor cell vaccineN Nishisaka, R F Jones, P Morse, et al.
Anticancer Research|May 1, 1994
Maintenance of human benign prostatic hyperplasia tissues in the nude mouseM Debiec-Rychter, K Asgari, R F Jones, et al.
Drugs|January 1, 1988
Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomyR L White, C H Nightingale, R Quintiliani, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Urology|June 1, 1980
Giant abdominal mass in a patient with an 18-year surgical cure of liposarcoma of the lower extremityR F Jones, T G Rudd, H J Ricketts, et al.
Urologic Oncology|January 14, 2011
Immunotherapy and gene therapy for renal cell carcinomaN Nishisaka, R F Jones, A Maini, et al.
Series Haematologica (1968)|January 1, 1971
Biologically active messenger-RNA for hemoglobinJ B Lingrel, R E Lockard, R F Jones, et al.
Virology|April 15, 1982
Mouse mammary tumor virus DNA sequences in tumorigenic and nontumorigenic cells from a mammary adenocarcinomaV L Morris, D A Gray, R F Jones, et al.
Anticancer Research|March 4, 2000
Expression of p53 and pRb in bladder and prostate cancers of patients having both cancersA Singh, R F Jones, H Friedman, et al.
Cancer Letters|May 18, 2000
Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the ratC L Archer, P Morse, R F Jones, et al.
Anticancer Research|September 1, 1995
Maintenance of human hyperplastic prostate implants at different sites in athymic miceG Soós, M Debiec-Rychter, R F Jones, et al.
Cytokines, Cellular & Molecular Therapy|September 22, 2001
Inhibition of lung metastases of murine renal cell carcinoma by the combination of radiation and interferon-alpha-producing tumor cell vaccineN Nishisaka, R F Jones, P Morse, et al.
Anticancer Research|May 1, 1994
Maintenance of human benign prostatic hyperplasia tissues in the nude mouseM Debiec-Rychter, K Asgari, R F Jones, et al.
Drugs|January 1, 1988
Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomyR L White, C H Nightingale, R Quintiliani, et al.
Pageof 18